
| Serial Number | 97632503 |
| Word Mark | ECR GLOBAL |
| Filing Date | Friday, October 14, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 3, 2024 |
| Registration Number | 7496635 |
| Registration Date | Tuesday, September 3, 2024 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 17, 2023 |
| Description of Mark | The mark consists of the literal element "ECR Global" in stylized font along with a curved line above the letters "lobal". |
| Pseudo Mark | ELIXIR CLINICAL RESEARCH GLOBAL |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Advertising relating to pharmaceutical products and in-vivo imaging products; Advertising services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Rental of advertising space |
| NOT AVAILABLE | "GLOBAL" |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 31, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | Wednesday, March 1, 2023 |
| First Use In Commerce Date | Wednesday, March 1, 2023 |
| Party Name | Elixir Clinical Research Co.,Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Shanghai 201103 CN |
| Party Name | Elixir Clinical Research Co.,Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Shanghai 201103 CN |
| Party Name | Elixir Clinical Research Co.,Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Shanghai 201103 CN |
| Event Date | Event Description |
| Tuesday, October 18, 2022 | NEW APPLICATION ENTERED |
| Monday, October 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 1, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Saturday, July 29, 2023 | ASSIGNED TO EXAMINER |
| Friday, August 4, 2023 | PRIORITY ACTION WRITTEN |
| Friday, August 4, 2023 | PRIORITY ACTION E-MAILED |
| Friday, August 4, 2023 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, September 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 17, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 17, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, June 26, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, December 12, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, May 20, 2024 | USE AMENDMENT FILED |
| Thursday, June 27, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, May 20, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Monday, July 29, 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, July 29, 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, September 3, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 3, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |